Merit Medical's Brian G. Lloyd sells 16,722 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Merit Medical Systems (MMSI) Chief Legal Officer and Secretary Brian G. Lloyd exercised options for 16,722 shares on November 16, 2026, at an exercise price of $37.71 per share, then sold 16,722 shares at a weighted-average $86.325 per share. The exercise and sale were made under a Rule 10b5-1 trading plan adopted May 21, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-qualified stock options (right to buy) F1, F3 | 16,722 | $0.00 | $0.00 |
| Exercise | Common Stock, No Par Value F1 | 16,722 | $37.71 | $631K |
| Sale | Common Stock, No Par Value F1, F2 | 16,722 | $86.325 | $1.44M |
| Holding | Non-qualified stock options (right to buy) F4 | -- | -- | -- |
| Holding | Non-qualified stock options (right to buy) F5 | -- | -- | -- |
| Holding | Non-qualified stock options (right to buy) F6 | -- | -- | -- |
| Holding | Common Stock, No Par Value | -- | -- | -- |
Footnotes (6)
- F1. The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2026.
- F2. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.88 to $86.90, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3. Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
- F4. Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
- F5. Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
- F6. Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Non-qualified stock options (right to buy) financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What direct MMSI option positions were listed for Brian G. Lloyd?
AI-generated analysis. How Rhea-AI works. Not financial advice.